US FDA’s draft guidance on OTC homeopathic products will confuse the industry, consumers and retailers and lead to the products being sold online only, the American Association of Homeopathy Pharmacists says in comments to the agency.
“Deleting the relative certainty in the current guidance would mean that many mass market sellers might find it difficult to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?